Teladoc Health, Inc. TDOC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 30.76% | 14.45% | 83.09% | 79.99% | 77.23% |
| Total Depreciation and Amortization | 10.92% | 5.13% | -5.17% | -16.41% | -24.29% |
| Total Amortization of Deferred Charges | -8.15% | -0.89% | 13.71% | 25.99% | 35.08% |
| Total Other Non-Cash Items | -64.87% | -52.79% | -92.47% | -87.65% | -85.53% |
| Change in Net Operating Assets | -148.03% | -300.59% | 123.83% | 102.96% | 121.32% |
| Cash from Operations | -8.25% | -13.92% | -4.23% | 0.23% | -13.42% |
| Capital Expenditure | 48.24% | 36.13% | 36.71% | 17.58% | -104.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 74.58% | 73.23% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.07% | 17.79% | -14.31% | -54.69% | -33.77% |
| Cash from Investing | 45.18% | 33.89% | 15.37% | -114.43% | -99.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -27.69% | -32.76% | -63.49% | -62.89% | -48.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 27.61% | -8,280.72% | -6,462.26% | -205,300.00% | -28.32% |
| Cash from Financing | 99.99% | 99.26% | -7,669.85% | -6,736.81% | -12,395.11% |
| Foreign Exchange rate Adjustments | -174.63% | -131.30% | 545.15% | 284.15% | -1.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.89% | 119.62% | -563.95% | -396.16% | -342.63% |